Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro‐oesophageal reflux disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|38|10|1303-1311

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.38, Iss.10, 2013-11, pp. : 1303-1311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care

By Ruigómez Ana   García Rodríguez Luis Alberto   Wallander Mari-Ann   Johansson Saga   Dent John  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1661-1668

Informa Healthcare

Access to resources Recommend Favorite

Identifying gastro-oesophageal reflux disease in infants

By Patience Sara  

Community Practitioner, Vol. 85, Iss. 11, 2012-11 ,pp. : 46-48

Community Practitioner

Access to resources Recommend Favorite

Gastro-oesophageal reflux disease: a re-appraisal

By Jones Roger  

British Journal of General Practice, Vol. 56, Iss. 531, 2006-10 ,pp. : 739-740

Royal College of General Practitioners

Access to resources Recommend Favorite

Gastro‐oesophageal reflux disease and Helicobacter pylori infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 16, Iss. s1, 2002-03 ,pp. : 47-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oesophageal signet ring cell carcinoma as complication of gastro‐oesophageal reflux disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1222-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite